GlycoSeLect opens raising round for Irish investors
Dublin- GlycoSeLect has opened a private equity raising round, targeted at Irish tax resident investors.
Investors in the round may be able to avail of the Irish Revenue Commissioners’ Employment & Investment Incentive Scheme (EIIS) allowing them to obtain income tax relief on investments in qualifying Small and Medium Enterprises (SMEs).
The Irish government, through Enterprise Ireland and its other agencies, has been very supportive of companies during the COVID-19 pandemic. This finance round will facilitate further investment and grants to develop our RPL technology in biopharmaceutical manufacturing, especially vaccine and cancer immunotherapy applications.
For more information on this investment opportunity, please contact our CEO, Robert Dunne, by email firstname.lastname@example.org or at GlycoSeLect Ltd phone number 01 2544164.